Free carnitine, acylcarnitine and total carnitine serum concentrations have been measured in chronic renal insufficiency patients under conservative treatment, in patients under regular haemodialysis treatment and in healthy controls. In the undialysed patients the levels of free camitine, acylcamitine and total carnitine were all clearly higher than those of the control group. The free carnitine and total carnitine levels of undialysed subjects were also higher than in regularly haemodialysed patients, showing that dialysis produces plasma carnitine losses that are not compensated for by endogenous synthesis of camitine (this finding supports published reports of tissue camitine deficiency in patients undergoing regular haemodialysis). The acylcarnitine levels of dialysed and undialysed patients were not significantly different, however; both were very much higher than that of control group. The hypercarnitinaemia of the patients under conservative treatment suggests that the impairment of renal function causes a reduction in the elimination of camitine via the kidney.
L-Camitine, which is synthesised in tissues from lysine and methionine, I is an essential cofactor for the transfer of long-chain fatty acids to mitochondria.I In the higher mammals its recycling is highly efficient, more than 90% of filtered L-camitine being re-absorbed by the kidneys at normal physiological plasma concentrations.:' and it is well established that chronic renal insufficiency patients undergoing regular dialysis treatment suffer from serum camitine deficiency.v" the suggested causes being either the loss of considerable quantities of carnitine during dialysis.i" s-tu or diminished endogenous synthesis of camitine. II It has been questioned.F' 13 however, whether a similar camitine deficiency develops in tissues, in spite of reports of reduced carnitine levels in the muscles of dialysed patients.l: 14 conservative treatment, and the few data available lack statistical support.": 1(" 17 Chen and Lincoln17 found that 17 of a group of 26 renal insufficiency patients had above-normal free carnitine levels, but their subjects included eight hepatic cirrhosis cases and various patients undergoing haemodialysis; Bohmer, Rydning and Solberg" found very high serum camitine concentrations in two patients with oliguria: Bartel et 'al. 6 also reported abovenormal serum carnitine concentrations in kidney disease patients not subjected to dialysis, but without providing statistical details. All these studies, moreover, refer to free carnitine, virtually nothing being known regarding acylcamitine and total camitine levels and their relationship with other parameters of renal function.
We report here plasma concentrations of free camitine, acylcarnitine and total camitine in two groups of chronic renal insufficiency patients, one undergoing haemodialysis three times a week and the other not subjected to haernodialysis, the aim being to establish, in the first place, whether undialysed patients exhibit hypercarnitinaemia as suggested by the few existing data, and secondly, whether haemodialysis produces hypocarnitinaemia.
Methods

PATIENTS
The undialysed group, selected at random from a population of chronic renal insufficiency patients, comprised 23 men and 11 women aged between 22 and 60 years. The basic diseases giving rise to the renal insufficiency were chronic interstitial nephropathy (14 patients), chronic glomerulopathy (16 patients) and polycystic kidneys (4 patients). Patients undergoing drug treatment of any kind and those suffering from associated metabolic disorders were excluded. The dialysed group, comprising 38 men and 16 women aged between 18 and 72 years, consisted of chronic renal insufficiency patients undergoing haemodialysis treatment three times a week. Forty-nine apparently healthy subjects aged between 20 and 56 years (30 men and 19 women) were used as a control group. AUTOMATED ASSAYS Urea was measured according to Ceriotti, 1M uric acid according to Caraway, 19 creatinine according to Heinegard and Tiderstrorrr" and cholesterol according to Allain et ai. 2 1 All these determinations were carried out using a Coulter Chemistry CA-3 ® autoanalyser (Coulter Electronics Inc., Hialeah, FL, USA). Triglycerides were determined by the method of Bucolo and David 22 in a CentrifiChem 600® centrifugal analyser (Baker Instruments Inc., Pleasantville, NY, USA). Determinations of free L-carnitine were carried out using a CentrifiChem 600 centrifugal analyser with the method described by Rodriguez-Segade et ai.,23 in which plasma samples are deproteinised by heating to 100°C and then freezing. Total carnitine concentrations (comprising both free and esterified forms) were obtained by the same procedure after acylcarnitine had been hydrolysed with 0·1 mol/L KOH (McGarry and Foster"). Acylcarnitine concentrations were calculated by subtracting free carnitine levels measured without alkaline hydrolysis from total carnitine concentrations. MATERIALS Carnitine acetyltransferase (CAT) from pigeon breast muscle (5 g/L), S-acetyl coenzyme A (trilithium salt), 5,5/ -dithiobis-2-nitrobenzoic acid (DTNB), EDTA, and Tris were purchased from Boehringer, Mannheim, FRG.
STATISTICAL ANALYSIS
Results are given as the arithmetic means±SD. Differences were analysed statistically by means of Student's t-test if the corresponding distribution was normal, and by Wilcoxon's test if not, and were considered significant at the 0·05 level.
Results
The renal insufficiency of the patients under conservative treatment was verified by measuring the plasma concentrations of urea, uric acid, creatinine, cholesterol and triglycerides in both this group and the controls. The values obtained in the former group for urea (70±25 mrnol/L), uric acid (0·53±0·12 rnrnol/L) and creatinine (884±513 !J.moVL) were significantly different from those of the control group (P<O·OOl). Serum triglyceride concentrations were also higher than in the normal population (P<O·OOI), and the mean triglyceride level of the two sexes also differed in undialysed chronic renal insufficiency patients (P<0·05). Cholesterol concentrations, on the other hand, exhibited no significant differences between undialysed patients and the control group, and neither was there any significant difference in this respect between the sexes in the former group. Thirty-seven and a half per cent of the undialysed patients had normal concentrations of both cholesterol and triglycerides, 9·4% had above-normal cholesterol concentrations, and 53·.1 % had above-normal triglyceride concentrations. The lipid profile chiefly reflects hyperlipoproteinaemia of Type IV (41%), followed by Type IIb (12%) and Type IIa (4%). Cholesterol concentrations were positively correlated with triglyceride concentrations in undialysed patients (r=0·595, P<O·OOI). No statistically significant correlation was observed between any form of carnitine and either cholesterol or triglyceride concentrations in undialysed patients. Table 1 lists the free carnitine, acylcarnitine and total carnitine concentrations measured in chronic renal insufficiency patients under conservative treatment, in regularly dialysed patients and in the control group. For all three forms of carnitine, the concentration observed in the undialysed patients was significantly higher than that in the control group (P<O·OOI). The free carnitine and total carnitine concentrations of the undialysed patients were also significantly higher than those of the dialysed patients (P<0·005), but there was no statistically significant difference between the acylcarnitine concentrations of these two groups. In the control group, but not in the undialysed patients, there were significant differences between the carnitine concentrations of the two sexes. Figure 1 shows the distribution of free carnitine, acylcarnitine and total carnitine concentrations in chronic renal insufficiency patients under conservative treatment. Nine undialysed patients (26%) had normal free carnitine and acylcarnitine concentrations, perhaps because renal insufficiency in these patients may have begun relatively recently.
The total carnitine concentration correlated significantly with both urea (r=0'419, P<O·01) (Fig. 2) and uric acid concentration (r=0·487, P<O·OOI) (Fig. 3) . Similarly, the free carnitine concentration correlated with both urea (r=0·460, P<0·02) and uric acid concentrations (r=0'529, P<O·01). However, no form of carnitine correlated significantly with creatinine, cholesterol or triglyceride concentrations. The concentrations of free carnitine (70,1 ±24·8 IlMIL) and total carnitine (97·1±39·9 IlM/L) in those undialysed patients with hypertriglyceridaemia were not only clearly higher than those in the control group, but .. ..
:
..
.. also slightly higher than those In the other undialysed patients.
Discussion
The plasma carnitine concentrations of uraemic patients under conservative treatment were clearly higher than those of normal subjects, confirming the indications of earlier studies.": 6. 17 One of the consequences of impaired kidney function would thus seem to be a reduction in the elimination of carnitine. We found the greatest differences, however, in acylcarnitine where plasma concentrations in the patients were extremely high compared with those in the control group. High acylcarnitine concentrations are also encountered in cases of diabetic acidosis 25 after prolonged fasting'" and in well-controlled diabetics.i? i.e . in situations in which there is increased oxidation of fatty acids. Since in normal subjects recovery of acylcarnitine by the kidneys is 4-8 times that of free camitine.j" it is possible that the alteration of the acylcarnitine/free carnitine ratio in patients may be due to their renal insuficiency having a proportionally greater effect on the recovery of acylcarnitine than on the recovery of free carnitine.
The results of this study indicate a lack of correlation between plasma creatinine and plasma carnitine values in undialysed patients and a poor correlation between plasma urea (Fig. 2 ) or plasma uric acid ( Fig. 3) and plasma carnitine values. Thus, the clinical significance of increased plasma carnitine in renal insufficiency might be different from that of plasma urea, plasma creatinine, or plasma uric acid.
Free carnitine and total carnitine concentrations were clearly higher in undialysed patients than in regularly dialysed patients (Table 1) . This finding strongly supports the hypothesis'': K-IO that dialysis produces loss of carnitine (plasma carnitine at least), and that these losses are not compensated for by increased endogenous carnitine synthesis. Since a statistically significant correlation has been observed 16 between plasma carnitine and muscular carnitine concentrations in uraemic patients under regular haemodialysis treatment, it seems highly probable that these patients suffer from tissue carnitine deficiency, a hypothesis which has been put forward on several occasions.t 14--16 but which has also met with opposition. 12, 13 
